Menu Close

Articles on Magnetic resonance imaging

Displaying all articles

Breast density is one of the factors that can influence whether people should pursue supplemental screening. andresr/E+ via Getty Images

The FDA’s rule change requiring providers to inform women about breast density could lead to a flurry of questions

Dense breast tissue is common and normal, but it can make cancer more difficult to detect. FDA requirements going into effect in September 2024 will dictate that patients be better informed about it.

Top contributors

More